On 2025-05-13, Candel Therapeutics, Inc. (CADL) announced earnings per share of $0.13 for the fiscal quarter ending 2025-03-31, beating the average analyst estimate of $-0.24.
The next expected annoucement date for quarterly earnings is 2025-08-12, with an average estimated earnings per share of $-0.17 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-13 | 2025-03-31 | $-0.24 | $0.13 |
| 2025-03-13 | 2024-12-31 | $-0.23 | $-0.40 |
| 2024-11-14 | 2024-09-30 | -- | $-0.33 |
| 2024-08-13 | 2024-06-30 | -- | $-0.74 |
| 2024-05-14 | 2024-03-31 | -- | $-0.28 |
| 2024-03-28 | 2023-12-31 | $-0.16 | $-0.38 |
| 2023-11-09 | 2023-09-30 | $-0.19 | $-0.29 |
| 2023-08-10 | 2023-06-30 | $-0.23 | $-0.33 |
| 2023-05-11 | 2023-03-31 | -- | $-0.30 |
| 2023-03-30 | 2022-12-31 | $-0.16 | $-0.18 |
| 2022-11-10 | 2022-09-30 | $-0.53 | $-0.30 |
| 2022-08-05 | 2022-06-30 | $-0.54 | $-0.14 |
| 2022-05-12 | 2022-03-31 | $-0.49 | $-0.03 |
| 2022-03-29 | 2021-12-31 | -- | $0.05 |
| 2021-11-12 | 2021-09-30 | $-0.27 | $-0.34 |
| 2021-09-08 | 2021-06-30 | $-0.36 | $-0.31 |